What is the timeline to develop a CDx with GenDx?

Every project is unique and will require a tailor-made project design. Typically, it takes approximately around 15 months from device to clinical trial assay, depending on many factors, including but not limited to clinical indication and assay validation status. If the project starts from a CE marked device with a different intended purpose (e.g. our NGSgo HLA devices), development timelines can often be streamlined and shortened.